Industry Research Reports
Global Pharma Contract Service Market Research Report 2026
Industry: Service & Software
Published Date: 2026-04-19
Pages: 120 Pages
Report ld: 6529360
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Pharma Contract Service Market Size(US$)
CAGR 2026-2032
7.3%
Market Size,2032
USD 262,570
Million
Market Snapshot
Market Size in 2026 (Value)
US$ 172,050 million
Market Forecast in 2032(Value)
US$ 262,570 million
CAGR
7.3%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Pharma Contract Service market was valued at US$ 161440 million in 2025 and is anticipated to reach US$ 262570 million by 2032, at a CAGR of 7.3% from 2026 to 2032.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report delivers a comprehensive overview of the global Pharma Contract Service market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Pharma Contract Service. The Pharma Contract Service market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Pharma Contract Service market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Pharma Contract Service manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
By Company
- ICON PLC
- IQVIA
- PPD
- Eurofins Scientific
- WuXi AppTec
- Labcorp Drug Development
- Syneos Health
- Parexel
- Medpace
- Charles River
- Lonza
- Aldevron
- Catalent
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Contract Research Organization (CRO)
- Contract Development and Manufacruring Organization (CDMO)
- Contract Manufacturing Organization (CMO)
Segment by Application
- Pharmaceutical Company
- Biotechnology Company
- Generic Company
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Pharma Contract Service companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharma Contract Service Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Contract Research Organization (CRO)
1.2.3 Contract Development and Manufacruring Organization (CDMO)
1.2.4 Contract Manufacturing Organization (CMO)
1.3 Market by Application
1.3.1 Global Pharma Contract Service Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Pharmaceutical Company
1.3.3 Biotechnology Company
1.3.4 Generic Company
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharma Contract Service Market Perspective (2021–2032)
2.2 Global Pharma Contract Service Growth Trends by Region
2.2.1 Global Pharma Contract Service Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Pharma Contract Service Historic Market Size by Region (2021–2026)
2.2.3 Pharma Contract Service Forecasted Market Size by Region (2027–2032)
2.3 Pharma Contract Service Market Dynamics
2.3.1 Pharma Contract Service Industry Trends
2.3.2 Pharma Contract Service Market Drivers
2.3.3 Pharma Contract Service Market Challenges
2.3.4 Pharma Contract Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharma Contract Service Players by Revenue
3.1.1 Global Top Pharma Contract Service Players by Revenue (2021–2026)
3.1.2 Global Pharma Contract Service Revenue Market Share by Players (2021–2026)
3.2 Global Top Pharma Contract Service Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Pharma Contract Service Revenue
3.4 Global Pharma Contract Service Market Concentration Ratio
3.4.1 Global Pharma Contract Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharma Contract Service Revenue in 2025
3.5 Global Key Players of Pharma Contract Service Head Offices and Areas Served
3.6 Global Key Players of Pharma Contract Service, Products and Applications
3.7 Global Key Players of Pharma Contract Service, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Pharma Contract Service Breakdown Data by Type
4.1 Global Pharma Contract Service Historic Market Size by Type (2021–2026)
4.2 Global Pharma Contract Service Forecasted Market Size by Type (2027–2032)
5 Pharma Contract Service Breakdown Data by Application
5.1 Global Pharma Contract Service Historic Market Size by Application (2021–2026)
5.2 Global Pharma Contract Service Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Pharma Contract Service Market Size (2021–2032)
6.2 North America Pharma Contract Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Pharma Contract Service Market Size by Country (2021–2026)
6.4 North America Pharma Contract Service Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharma Contract Service Market Size (2021–2032)
7.2 Europe Pharma Contract Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Pharma Contract Service Market Size by Country (2021–2026)
7.4 Europe Pharma Contract Service Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Pharma Contract Service Market Size (2021–2032)
8.2 Asia-Pacific Pharma Contract Service Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Pharma Contract Service Market Size by Region (2021–2026)
8.4 Asia-Pacific Pharma Contract Service Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Pharma Contract Service Market Size (2021–2032)
9.2 Latin America Pharma Contract Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Pharma Contract Service Market Size by Country (2021–2026)
9.4 Latin America Pharma Contract Service Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharma Contract Service Market Size (2021–2032)
10.2 Middle East & Africa Pharma Contract Service Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Pharma Contract Service Market Size by Country (2021–2026)
10.4 Middle East & Africa Pharma Contract Service Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ICON PLC
11.1.1 ICON PLC Company Details
11.1.2 ICON PLC Business Overview
11.1.3 ICON PLC Pharma Contract Service Introduction
11.1.4 ICON PLC Revenue in Pharma Contract Service Business (2021–2026)
11.1.5 ICON PLC Recent Development
11.2 IQVIA
11.2.1 IQVIA Company Details
11.2.2 IQVIA Business Overview
11.2.3 IQVIA Pharma Contract Service Introduction
11.2.4 IQVIA Revenue in Pharma Contract Service Business (2021–2026)
11.2.5 IQVIA Recent Development
11.3 PPD
11.3.1 PPD Company Details
11.3.2 PPD Business Overview
11.3.3 PPD Pharma Contract Service Introduction
11.3.4 PPD Revenue in Pharma Contract Service Business (2021–2026)
11.3.5 PPD Recent Development
11.4 Eurofins Scientific
11.4.1 Eurofins Scientific Company Details
11.4.2 Eurofins Scientific Business Overview
11.4.3 Eurofins Scientific Pharma Contract Service Introduction
11.4.4 Eurofins Scientific Revenue in Pharma Contract Service Business (2021–2026)
11.4.5 Eurofins Scientific Recent Development
11.5 WuXi AppTec
11.5.1 WuXi AppTec Company Details
11.5.2 WuXi AppTec Business Overview
11.5.3 WuXi AppTec Pharma Contract Service Introduction
11.5.4 WuXi AppTec Revenue in Pharma Contract Service Business (2021–2026)
11.5.5 WuXi AppTec Recent Development
11.6 Labcorp Drug Development
11.6.1 Labcorp Drug Development Company Details
11.6.2 Labcorp Drug Development Business Overview
11.6.3 Labcorp Drug Development Pharma Contract Service Introduction
11.6.4 Labcorp Drug Development Revenue in Pharma Contract Service Business (2021–2026)
11.6.5 Labcorp Drug Development Recent Development
11.7 Syneos Health
11.7.1 Syneos Health Company Details
11.7.2 Syneos Health Business Overview
11.7.3 Syneos Health Pharma Contract Service Introduction
11.7.4 Syneos Health Revenue in Pharma Contract Service Business (2021–2026)
11.7.5 Syneos Health Recent Development
11.8 Parexel
11.8.1 Parexel Company Details
11.8.2 Parexel Business Overview
11.8.3 Parexel Pharma Contract Service Introduction
11.8.4 Parexel Revenue in Pharma Contract Service Business (2021–2026)
11.8.5 Parexel Recent Development
11.9 Medpace
11.9.1 Medpace Company Details
11.9.2 Medpace Business Overview
11.9.3 Medpace Pharma Contract Service Introduction
11.9.4 Medpace Revenue in Pharma Contract Service Business (2021–2026)
11.9.5 Medpace Recent Development
11.10 Charles River
11.10.1 Charles River Company Details
11.10.2 Charles River Business Overview
11.10.3 Charles River Pharma Contract Service Introduction
11.10.4 Charles River Revenue in Pharma Contract Service Business (2021–2026)
11.10.5 Charles River Recent Development
11.11 Lonza
11.11.1 Lonza Company Details
11.11.2 Lonza Business Overview
11.11.3 Lonza Pharma Contract Service Introduction
11.11.4 Lonza Revenue in Pharma Contract Service Business (2021–2026)
11.11.5 Lonza Recent Development
11.12 Aldevron
11.12.1 Aldevron Company Details
11.12.2 Aldevron Business Overview
11.12.3 Aldevron Pharma Contract Service Introduction
11.12.4 Aldevron Revenue in Pharma Contract Service Business (2021–2026)
11.12.5 Aldevron Recent Development
11.13 Catalent
11.13.1 Catalent Company Details
11.13.2 Catalent Business Overview
11.13.3 Catalent Pharma Contract Service Introduction
11.13.4 Catalent Revenue in Pharma Contract Service Business (2021–2026)
11.13.5 Catalent Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Pharma Contract Service Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Contract Research Organization (CRO)
Table 3. Key Players of Contract Development and Manufacruring Organization (CDMO)
Table 4. Key Players of Contract Manufacturing Organization (CMO)
Table 5. Global Pharma Contract Service Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Pharma Contract Service Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 7. Global Pharma Contract Service Market Size by Region (US$ Million), 2021–2026
Table 8. Global Pharma Contract Service Market Share by Region (2021–2026)
Table 9. Global Pharma Contract Service Forecasted Market Size by Region (US$ Million), 2027–2032
Table 10. Global Pharma Contract Service Market Share by Region (2027–2032)
Table 11. Pharma Contract Service Market Trends
Table 12. Pharma Contract Service Market Drivers
Table 13. Pharma Contract Service Market Challenges
Table 14. Pharma Contract Service Market Restraints
Table 15. Global Pharma Contract Service Revenue by Players (US$ Million), 2021–2026
Table 16. Global Pharma Contract Service Market Share by Players (2021–2026)
Table 17. Global Top Pharma Contract Service Players by Tier (Tier 1, Tier 2, and Tier 3), based on Pharma Contract Service Revenue, 2025
Table 18. Ranking of Global Top Pharma Contract Service Companies by Revenue (US$ Million) in 2025
Table 19. Global 5 Largest Players Market Share by Pharma Contract Service Revenue (CR5 and HHI), 2021–2026
Table 20. Global Key Players of Pharma Contract Service, Headquarters and Area Served
Table 21. Global Key Players of Pharma Contract Service, Products and Applications
Table 22. Global Key Players of Pharma Contract Service, Date of General Availability (GA)
Table 23. Mergers and Acquisitions, Expansion Plans
Table 24. Global Pharma Contract Service Market Size by Type (US$ Million), 2021–2026
Table 25. Global Pharma Contract Service Revenue Market Share by Type (2021–2026)
Table 26. Global Pharma Contract Service Forecasted Market Size by Type (US$ Million), 2027–2032
Table 27. Global Pharma Contract Service Revenue Market Share by Type (2027–2032)
Table 28. Global Pharma Contract Service Market Size by Application (US$ Million), 2021–2026
Table 29. Global Pharma Contract Service Revenue Market Share by Application (2021–2026)
Table 30. Global Pharma Contract Service Forecasted Market Size by Application (US$ Million), 2027–2032
Table 31. Global Pharma Contract Service Revenue Market Share by Application (2027–2032)
Table 32. North America Pharma Contract Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 33. North America Pharma Contract Service Market Size by Country (US$ Million), 2021–2026
Table 34. North America Pharma Contract Service Market Size by Country (US$ Million), 2027–2032
Table 35. Europe Pharma Contract Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 36. Europe Pharma Contract Service Market Size by Country (US$ Million), 2021–2026
Table 37. Europe Pharma Contract Service Market Size by Country (US$ Million), 2027–2032
Table 38. Asia-Pacific Pharma Contract Service Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 39. Asia-Pacific Pharma Contract Service Market Size by Region (US$ Million), 2021–2026
Table 40. Asia-Pacific Pharma Contract Service Market Size by Region (US$ Million), 2027–2032
Table 41. Latin America Pharma Contract Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 42. Latin America Pharma Contract Service Market Size by Country (US$ Million), 2021–2026
Table 43. Latin America Pharma Contract Service Market Size by Country (US$ Million), 2027–2032
Table 44. Middle East & Africa Pharma Contract Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 45. Middle East & Africa Pharma Contract Service Market Size by Country (US$ Million), 2021–2026
Table 46. Middle East & Africa Pharma Contract Service Market Size by Country (US$ Million), 2027–2032
Table 47. ICON PLC Company Details
Table 48. ICON PLC Business Overview
Table 49. ICON PLC Pharma Contract Service Product
Table 50. ICON PLC Revenue in Pharma Contract Service Business (US$ Million), 2021–2026
Table 51. ICON PLC Recent Development
Table 52. IQVIA Company Details
Table 53. IQVIA Business Overview
Table 54. IQVIA Pharma Contract Service Product
Table 55. IQVIA Revenue in Pharma Contract Service Business (US$ Million), 2021–2026
Table 56. IQVIA Recent Development
Table 57. PPD Company Details
Table 58. PPD Business Overview
Table 59. PPD Pharma Contract Service Product
Table 60. PPD Revenue in Pharma Contract Service Business (US$ Million), 2021–2026
Table 61. PPD Recent Development
Table 62. Eurofins Scientific Company Details
Table 63. Eurofins Scientific Business Overview
Table 64. Eurofins Scientific Pharma Contract Service Product
Table 65. Eurofins Scientific Revenue in Pharma Contract Service Business (US$ Million), 2021–2026
Table 66. Eurofins Scientific Recent Development
Table 67. WuXi AppTec Company Details
Table 68. WuXi AppTec Business Overview
Table 69. WuXi AppTec Pharma Contract Service Product
Table 70. WuXi AppTec Revenue in Pharma Contract Service Business (US$ Million), 2021–2026
Table 71. WuXi AppTec Recent Development
Table 72. Labcorp Drug Development Company Details
Table 73. Labcorp Drug Development Business Overview
Table 74. Labcorp Drug Development Pharma Contract Service Product
Table 75. Labcorp Drug Development Revenue in Pharma Contract Service Business (US$ Million), 2021–2026
Table 76. Labcorp Drug Development Recent Development
Table 77. Syneos Health Company Details
Table 78. Syneos Health Business Overview
Table 79. Syneos Health Pharma Contract Service Product
Table 80. Syneos Health Revenue in Pharma Contract Service Business (US$ Million), 2021–2026
Table 81. Syneos Health Recent Development
Table 82. Parexel Company Details
Table 83. Parexel Business Overview
Table 84. Parexel Pharma Contract Service Product
Table 85. Parexel Revenue in Pharma Contract Service Business (US$ Million), 2021–2026
Table 86. Parexel Recent Development
Table 87. Medpace Company Details
Table 88. Medpace Business Overview
Table 89. Medpace Pharma Contract Service Product
Table 90. Medpace Revenue in Pharma Contract Service Business (US$ Million), 2021–2026
Table 91. Medpace Recent Development
Table 92. Charles River Company Details
Table 93. Charles River Business Overview
Table 94. Charles River Pharma Contract Service Product
Table 95. Charles River Revenue in Pharma Contract Service Business (US$ Million), 2021–2026
Table 96. Charles River Recent Development
Table 97. Lonza Company Details
Table 98. Lonza Business Overview
Table 99. Lonza Pharma Contract Service Product
Table 100. Lonza Revenue in Pharma Contract Service Business (US$ Million), 2021–2026
Table 101. Lonza Recent Development
Table 102. Aldevron Company Details
Table 103. Aldevron Business Overview
Table 104. Aldevron Pharma Contract Service Product
Table 105. Aldevron Revenue in Pharma Contract Service Business (US$ Million), 2021–2026
Table 106. Aldevron Recent Development
Table 107. Catalent Company Details
Table 108. Catalent Business Overview
Table 109. Catalent Pharma Contract Service Product
Table 110. Catalent Revenue in Pharma Contract Service Business (US$ Million), 2021–2026
Table 111. Catalent Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
Table 115. Authors List of This Report
List of Figures
Figure 1. Pharma Contract Service Picture
Figure 2. Global Pharma Contract Service Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Pharma Contract Service Market Share by Type: 2025 vs 2032
Figure 4. Contract Research Organization (CRO) Features
Figure 5. Contract Development and Manufacruring Organization (CDMO) Features
Figure 6. Contract Manufacturing Organization (CMO) Features
Figure 7. Global Pharma Contract Service Market Size by Application (US$ Million), 2021–2032
Figure 8. Global Pharma Contract Service Market Share by Application: 2025 vs 2032
Figure 9. Pharmaceutical Company Case Studies
Figure 10. Biotechnology Company Case Studies
Figure 11. Generic Company Case Studies
Figure 12. Pharma Contract Service Report Years Considered
Figure 13. Global Pharma Contract Service Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 14. Global Pharma Contract Service Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global Pharma Contract Service Market Share by Region: 2025 vs 2032
Figure 16. Global Pharma Contract Service Market Share by Players in 2025
Figure 17. Global Pharma Contract Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by Pharma Contract Service Revenue in 2025
Figure 19. North America Pharma Contract Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 20. North America Pharma Contract Service Market Share by Country (2021–2032)
Figure 21. United States Pharma Contract Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Canada Pharma Contract Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe Pharma Contract Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Pharma Contract Service Market Share by Country (2021–2032)
Figure 25. Germany Pharma Contract Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. France Pharma Contract Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. U.K. Pharma Contract Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Italy Pharma Contract Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Russia Pharma Contract Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Ireland Pharma Contract Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific Pharma Contract Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Pharma Contract Service Market Share by Region (2021–2032)
Figure 33. China Pharma Contract Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Japan Pharma Contract Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. South Korea Pharma Contract Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Southeast Asia Pharma Contract Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. India Pharma Contract Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Australia & New Zealand Pharma Contract Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America Pharma Contract Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Pharma Contract Service Market Share by Country (2021–2032)
Figure 41. Mexico Pharma Contract Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Brazil Pharma Contract Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa Pharma Contract Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Pharma Contract Service Market Share by Country (2021–2032)
Figure 45. Israel Pharma Contract Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Saudi Arabia Pharma Contract Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. UAE Pharma Contract Service Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. ICON PLC Revenue Growth Rate in Pharma Contract Service Business (2021–2026)
Figure 49. IQVIA Revenue Growth Rate in Pharma Contract Service Business (2021–2026)
Figure 50. PPD Revenue Growth Rate in Pharma Contract Service Business (2021–2026)
Figure 51. Eurofins Scientific Revenue Growth Rate in Pharma Contract Service Business (2021–2026)
Figure 52. WuXi AppTec Revenue Growth Rate in Pharma Contract Service Business (2021–2026)
Figure 53. Labcorp Drug Development Revenue Growth Rate in Pharma Contract Service Business (2021–2026)
Figure 54. Syneos Health Revenue Growth Rate in Pharma Contract Service Business (2021–2026)
Figure 55. Parexel Revenue Growth Rate in Pharma Contract Service Business (2021–2026)
Figure 56. Medpace Revenue Growth Rate in Pharma Contract Service Business (2021–2026)
Figure 57. Charles River Revenue Growth Rate in Pharma Contract Service Business (2021–2026)
Figure 58. Lonza Revenue Growth Rate in Pharma Contract Service Business (2021–2026)
Figure 59. Aldevron Revenue Growth Rate in Pharma Contract Service Business (2021–2026)
Figure 60. Catalent Revenue Growth Rate in Pharma Contract Service Business (2021–2026)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Pharma Contract Service market?
The top companies in the global Pharma Contract Service market are ICON PLC、IQVIA、PPD.
What was the global market size of Pharma Contract Service in 2032?
What is the annual compound growth rate of the global Pharma Contract Service market size from 2026 to 2032?
Which region is expected to have the highest market share?
What was the global market size of Pharma Contract Service in 2026?
Related Reports
Pharma Contract Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Pharma Contract Service was estimated to be worth US$ 161440 million in 2025 and is projected to reach US$ 262570 million, growing at a CAGR of 7.3% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 114
USD 3950.00
(Single User License)
Global Pharma Contract Service Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Pharma Contract Service market size was US$ 151490 million in 2024 and is forecast to a readjusted size of US$ 246380 million by 2031 with a CAGR of 7.3% during the forecast period 2025-2031.
Published Date: 2025-11-17
Pages: 91
USD 4250.00
(Single User License)
Global Pharma Contract Service Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Pharma Contract Service market is projected to grow from US$ 151490 million in 2024 to US$ 246380 million by 2031, at a CAGR of 7.3% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-11-16
Pages: 140
USD 4900.00
(Single User License)
Global Pharma Contract Service Market Research Report 2025
The global market for Pharma Contract Service was valued at US$ 151490 million in the year 2024 and is projected to reach a revised size of US$ 246380 million by 2031, growing at a CAGR of 7.3% during the forecast period.
Published Date: 2025-02-04
Pages: 90
USD 2900.00
(Single User License)
Pharma Contract Service- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Pharma Contract Service was estimated to be worth US$ 151490 million in 2024 and is forecast to a readjusted size of US$ 246380 million by 2031 with a CAGR of 7.3% during the forecast period 2025-2031.
Published Date: 2025-02-04
Pages: 112
USD 3950.00
(Single User License)
Pharma Contract Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Pharma Contract Service was estimated to be worth US$ 161440 million in 2025 and is projected to reach US$ 262570 million, growing at a CAGR of 7.3% from 2026 to 2032.
Published: 2026-06-16
Pages: 114
USD 3950.00 (Single User License)Global Pharma Contract Service Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Pharma Contract Service market size was US$ 151490 million in 2024 and is forecast to a readjusted size of US$ 246380 million by 2031 with a CAGR of 7.3% during the forecast period 2025-2031.
Published: 2025-11-17
Pages: 91
USD 4250.00 (Single User License)Global Pharma Contract Service Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Pharma Contract Service market is projected to grow from US$ 151490 million in 2024 to US$ 246380 million by 2031, at a CAGR of 7.3% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-11-16
Pages: 140
USD 4900.00 (Single User License)Global Pharma Contract Service Market Research Report 2025
The global market for Pharma Contract Service was valued at US$ 151490 million in the year 2024 and is projected to reach a revised size of US$ 246380 million by 2031, growing at a CAGR of 7.3% during the forecast period.
Published: 2025-02-04
Pages: 90
USD 2900.00 (Single User License)Pharma Contract Service- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Pharma Contract Service was estimated to be worth US$ 151490 million in 2024 and is forecast to a readjusted size of US$ 246380 million by 2031 with a CAGR of 7.3% during the forecast period 2025-2031.
Published: 2025-02-04
Pages: 112
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 2900.00
USD 4350.00
USD 5800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now